Axiogenesis

Koln, Germany Founded: 2000 • Age: 26 yrs
Generic medicines are sold via an online pharmacy platform.
Request Access

About Axiogenesis

Axiogenesis is a company based in Koln (Germany) founded in 2000.. Axiogenesis operates in a competitive market with competitors including MAYD, medpex, Medizinfuchs, FIRST A and Sanicare, among others.

  • Headquarter Koln, Germany
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Jurisdiction Bangalore North, Karnataka, India
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
    $403.09 K (USD)
    19.31
    as on Mar 31, 2022
  • Net Profit
    $26.11 K (USD)
    -14.87
    as on Mar 31, 2022
  • EBITDA
    $31.2 K (USD)
    28.43
    as on Mar 31, 2022
  • Latest Funding Round
    $615.66 K (USD), Grant

    Nov 01, 2016

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Axiogenesis

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $615,661
  • First Round

    (01 Jun 2015)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2016 Amount Grant - Axiogenesis Valuation

investors

May, 2016 Amount Series A - Axiogenesis Valuation Sino-German High-Tech Fund
Jun, 2015 Amount Grant - Axiogenesis Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Axiogenesis

Axiogenesis has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Huizhong Diagnostics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Huizhong Diagnostics is engaged in developing medical diagnostic solutions.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Axiogenesis

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Axiogenesis

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Axiogenesis Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Axiogenesis

Axiogenesis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MAYD, medpex, Medizinfuchs, FIRST A and Sanicare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Non-prescription medicines are ordered and delivered online.
domain founded_year HQ Location
Medicines for health conditions are sold online by medpex.
domain founded_year HQ Location
Operates a marketplace for pharmacy products to facilitate online purchasing.
domain founded_year HQ Location
A mobile app for online medicine ordering is provided.
domain founded_year HQ Location
Online pharmacy products are offered across various health categories.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Axiogenesis

Frequently Asked Questions about Axiogenesis

When was Axiogenesis founded?

Axiogenesis was founded in 2000 and raised its 1st funding round 15 years after it was founded.

Where is Axiogenesis located?

Axiogenesis is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.

What is the annual revenue of Axiogenesis?

Annual revenue of Axiogenesis is $403.09K as on Mar 31, 2022.

What does Axiogenesis do?

Axiogenesis was established in 2000 in Cologne, Germany, as an online pharmacy. Generic medicines are distributed through the platform, which operates in the healthcare sector. Specific drugs can be searched by users according to their requirements. The service focuses on pharmaceutical accessibility, with operations centered in Europe. The domain axiogenesis.com supports these activities.

Who are the top competitors of Axiogenesis?

Axiogenesis's top competitors include MAYD, medpex and FIRST A.

Who are Axiogenesis's investors?

Axiogenesis has 2 investors. Key investors include European Union, and Huizhong Diagnostics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available